Just some thoughts from a overthinking relatively new BOT investor. . .
After digesting the webinar and reading between the lines I am now convinced the IT platforms that will underpin the sofdra release will be company making in their own right. . .
It is quite possible that the "instructions for use" were actually available but were intended to be included digitally within the SOFRA app/platform to draw patients/practitioners into the IT ecosystem. BUT . . . the FDA needed the paper written ones included.
This would explain why the resubmission was so timely.
I have said it before but I think BOT is waiting for FDA approval not only for drug commercialisation but also for showcasing the revolutionary IT platforms. . . script refill, practitioner/patient care (aka aftercare)
Then other companies can pay us $$$ for product release and the aftercare . . .
AIMO
- Forums
- ASX - By Stock
- BOT - Anything but charting
Just some thoughts from a overthinking relatively new BOT...
-
- There are more pages in this discussion • 1,618 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.3¢ |
Change
0.023(6.43%) |
Mkt cap ! $674.2M |
Open | High | Low | Value | Volume |
35.5¢ | 37.3¢ | 35.5¢ | $1.077M | 2.944M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 541328 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 465079 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 402591 | 0.370 |
5 | 120242 | 0.365 |
6 | 238890 | 0.360 |
8 | 321662 | 0.355 |
10 | 538705 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 415079 | 12 |
0.380 | 543897 | 21 |
0.385 | 398377 | 8 |
0.390 | 226909 | 10 |
0.395 | 359500 | 7 |
Last trade - 10.51am 30/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |